Associated Papers
Potential Opportunities for Pharmacogenetic-Based Therapeutic Exploitation of Xanthine Dehydrogenase in Cardiovascular Disease.
Massimo G et al.
Antioxidants (basel, Switzerland), 2024
Hypouricaemia in a patient with hereditary xanthinuria type I.
Maes B et al.
Lancet (london, England), 2024
Three cases of xanthinuria identified by gas chromatography/mass spectrometry-based urine metabolomics.
Kuhara T et al.
Iju Case Reports, 2023
Somatic Evolution in Non-neoplastic IBD-Affected Colon.
Olafsson S et al.
Cell, 2020
32697969 (PubMed )
Supplement: mmc3.xlsx › A__Coding_mutations_IBD
An ancestral variant causing type I xanthinuria in Turkmen and Arab families is predicted to prevail in the Afro-Asian stone-forming belt.
Peretz H et al.
Jimd Reports, 2020
Xanthinuria type I with a novel mutation of xanthine dehydrogenase.
Tanaka K et al.
The American Journal of the Medical Sciences, 2015
Select a paper to view details